Similar Articles
New Developments in Parkinson's Disease Management
M. Cenk AKBOSTANCI
Issue: 1998, Volume 4 - Issue 1-2
0
245
Magnesium for migraine prophylaxis: A Double-Blind Plascebo Controlled Trial
Şeref DEMİRKAYA, Okay VURAL, Zeki GÖKÇİL, Erdal EROĞLU, Fatih ÖZDAĞ, Muzaffer YARDIM
Issue: 1997, Volume 3 - Issue 3-4
0
227
CREUTZFELDT-JAKOB DISEASE: The Clinico-Pathological Evaluation of 12 Patients.
Sultan TARLACI, Ayşe SAĞDUYU ÖZKAYA, Hadiye ŞİRİN
Issue: 1996, Volume 2 - Issue 1-2
0
646
Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.
Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA
Issue: 1995, Volume 1 - Issue 3
0
224
Creutzfeldt-Jakob Disease: Report of Two Cases and Review of Turkish Literature
Aytaç YİĞİT, Serpil DEMİRCİ, Nermin MUTLUER
Issue: 1995, Volume 1 - Issue 2
0
209
THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS
Bülent ELİBOL
Issue: 1995, Volume 1 - Issue 1
0
274
Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN
Issue: 1995, Volume 1 - Issue 1
0
248
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU
Issue: 2009, Volume 15 - Supplement 3
0
311
Clinical and Radiological Features of Multiple Sclerosis: Three Case Reports
Murat TERZİ
Issue: 2009, Volume 15 - Supplement 3
0
463
The potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment
Firat Karaaslan, Reşit Yilmaz, Fidel Demir, Müttalip Özbek, İbrahim Kaplan, Eşref Akil
DOI: 10.55697/tnd.2025.216
Issue: 2025, Volume 31 - Issue 1
207
142